Aulos Bioscience is a startup. Brouky records 1 investor associated with the company.
Aulos Bioscience is a clinical-stage biotechnology company developing imneskibart, a therapeutic candidate for cancer. The company has reported Phase 1/2 and Phase 2 clinical data in melanoma and non-small cell lung cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.